Quality of life in patients with locally advanced head and neck cancer treated with concurrent chemoradiation with cisplatin and nimotuzumab versus cisplatin alone – Additional data from a phase 3 trial-Reference-Cited by-同舟云学术

Quality of life in patients with locally advanced head and neck cancer treated with concurrent chemoradiation with cisplatin and nimotuzumab versus cisplatin alone – Additional data from a phase 3 trial

Published:2021-11 Issue: Volume:122 Page:105517
ISSN:1368-8375
Container-title:Oral Oncology
language:en
Short-container-title:Oral Oncology

Author:

Menon Nandini^ORCID,Patil Vijay,Noronha Vanita,Joshi Amit,Bhattacharjee Atanu,Satam Balajirao J,Mathrudev Vijayalakshmi,Ghosh Laskar Sarbani,Prabhash Kumar

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Oral Surgery

Reference19 articles.

1. Head and neck cancers, version 2.2013. Featured updates to the NCCN guidelines;Pfister;J Natl Compr Canc Netw.,2013

2. EHNS–ESMO–ESTRO Guidelines Working Group. Squamous cell carcinoma of the head and neck: EHNS-ESMO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up;Gregoire;Ann Oncol.,2010

3. Induction TPF followed by concomitant treatment versus concomitant treatment alone in locally advanced head and neck cancer;Ghi;A phase II-III trial. Ann Oncol.,2017

4. Individual patient data meta-analyses in head and neck carcinoma: what have we learnt?;Pignon;Cancer Radiother.,2005

5. Randomized phase III trial to test accelerated versus standard fractionation in combination with concurrent cisplatin for head and neck carcinomas in the Radiation Therapy Oncology Group 0129 trial: long-term report of efficacy and toxicity;Nguyen-Tan;J Clin Oncol.,2014

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular pathways and targeted therapies in head and neck cancers pathogenesis;Frontiers in Oncology;2024-06-17

2. Anti‑epidermal growth factor receptor monoclonal antibody therapy in locally advanced head and neck cancer: A systematic review of phase III clinical trials;Medicine International;2024-05-29

3. The epigenetic downregulation of LncGHRLOS mediated by RNA m6A methylase ZCCHC4 promotes colorectal cancer tumorigenesis;Journal of Experimental & Clinical Cancer Research;2024-02-07

4. Indian clinical practice consensus guidelines for the management of laryngeal cancer: Update 2022;Cancer Research, Statistics, and Treatment;2024-01

5. Indian clinical practice consensus guidelines for the management of oropharyngeal cancer: Update 2022;Cancer Research, Statistics, and Treatment;2024-01